{"id":45874,"date":"2020-06-12T03:00:24","date_gmt":"2020-06-12T01:00:24","guid":{"rendered":"https:\/\/www.cde.ual.es\/?p=45874"},"modified":"2020-06-11T12:40:56","modified_gmt":"2020-06-11T10:40:56","slug":"eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing","status":"publish","type":"post","link":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/","title":{"rendered":"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing"},"content":{"rendered":"<p>The <strong>European Investment Bank (EIB)<\/strong> and <strong>BioNTech<\/strong> (Nasdaq: BNTX, BioNTech) have concluded a <strong>\u20ac100 million debt financing agreement<\/strong> to support the development of BNT162, the company&#8217;s COVID-19 vaccine programme. The deal will also allow the company to expand its manufacturing capacity in order to supply the vaccine fast worldwide in response to the pandemic. This will be done at the company&#8217;s own risk while the clinical studies are ongoing. BioNTech became the first European company to enter clinical testing, having started a clinical trial in Germany in April and a further clinical trial in the United States at the beginning of May. BioNTech&#8217;s development programme for BNT162 is one of the broadest development programmes globally, with four vaccine candidates being tested in parallel.<\/p>\n<h3>Debt Investment<\/h3>\n<p>The EIB debt investment will be disbursed in two tranches of \u20ac50\u00a0million each, following completion of pre-defined milestones. It is backed by the\u00a0<a href=\"https:\/\/www.eib.org\/en\/efsi\/index.htm\">European Fund for Strategic Investments<\/a>, the financial heart of the Investment Plan for Europe, in which the EIB and the European Commission partner to kick-off investment for EU priority projects. It also benefits from\u00a0<a href=\"https:\/\/ec.europa.eu\/programmes\/horizon2020\/en\/h2020-section\/access-risk-finance\">InnovFin Risk Sharing<\/a>\u00a0for Corporate Research backed by Horizon 2020, the EU Framework Programme for Research and Innovation.<\/p>\n<p>BioNTech already entered into a<strong> \u20ac50 million venture debt agreement under the European Growth Finance Facility<\/strong> for its personalised cancer immunotherapy programme in December 2019. The financing was part of broader EIB activities in the life sciences sector. Some 50 European companies in the life sciences industry have received a total of \u20ac1.3\u00a0billion, backed by the European Fund for Strategic Investments, over the last four years.<\/p>\n<h3>More information<\/h3>\n<p class=\"ecl-heading ecl-heading--h1 ecl-u-color-white\"><a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/IP_20_1034\">Investment Plan for Europe &#8211; European Commission Press Release\u00a0<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Investment Bank (EIB) and BioNTech (Nasdaq: BNTX, BioNTech) have concluded a \u20ac100 million debt financing agreement to support the development of BNT162, the company&#8217;s COVID-19 vaccine programme. The deal will also allow the company to expand its manufacturing capacity in order to supply the vaccine fast worldwide in response to the pandemic. This [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16452,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4093,4090,346,4094,4088,157],"tags":[1322,381],"class_list":{"0":"post-45874","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-diseases","8":"category-economy-finance","9":"category-eu-news","10":"category-farmac","11":"category-market","12":"category-uncategorized","13":"tag-coronavirus-en","14":"tag-salud-en","15":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"og:description\" content=\"The European Investment Bank (EIB) and BioNTech (Nasdaq: BNTX, BioNTech) have concluded a \u20ac100 million debt financing agreement to support the development of BNT162, the company&#8217;s COVID-19 vaccine programme. The deal will also allow the company to expand its manufacturing capacity in order to supply the vaccine fast worldwide in response to the pandemic. This [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/\" \/>\n<meta property=\"og:site_name\" content=\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-12T01:00:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png\" \/>\n\t<meta property=\"og:image:width\" content=\"927\" \/>\n\t<meta property=\"og:image:height\" content=\"585\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"AdminCDE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:site\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"AdminCDE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/\"},\"author\":{\"name\":\"AdminCDE\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/224ef08c8bcc005f319d2713ce37ee5f\"},\"headline\":\"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing\",\"datePublished\":\"2020-06-12T01:00:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/\"},\"wordCount\":292,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"keywords\":[\"Coronavirus\",\"Salud\"],\"articleSection\":[\"Diseases\",\"Economy and Finance\",\"EU News\",\"Farmaceutical\",\"Market\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/\",\"name\":\"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"datePublished\":\"2020-06-12T01:00:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"width\":927,\"height\":585},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU News\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Health\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/health\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Diseases\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/health\\\/diseases\\\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"name\":\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"description\":\"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"alternateName\":\"CDE Almer\u00eda\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cde.ual.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\",\"name\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"width\":1400,\"height\":300,\"caption\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cdeuniversidadalmeria\\\/\",\"https:\\\/\\\/x.com\\\/cdeualmeria\",\"https:\\\/\\\/www.tiktok.com\\\/@cdealmeria\",\"https:\\\/\\\/www.instagram.com\\\/cdealmeria\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cde-almera-812b26a9\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/224ef08c8bcc005f319d2713ce37ee5f\",\"name\":\"AdminCDE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g\",\"caption\":\"AdminCDE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/","og_locale":"en_US","og_type":"article","og_title":"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","og_description":"The European Investment Bank (EIB) and BioNTech (Nasdaq: BNTX, BioNTech) have concluded a \u20ac100 million debt financing agreement to support the development of BNT162, the company&#8217;s COVID-19 vaccine programme. The deal will also allow the company to expand its manufacturing capacity in order to supply the vaccine fast worldwide in response to the pandemic. This [&hellip;]","og_url":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/","og_site_name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","article_publisher":"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","article_published_time":"2020-06-12T01:00:24+00:00","og_image":[{"width":927,"height":585,"url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","type":"image\/png"}],"author":"AdminCDE","twitter_card":"summary_large_image","twitter_creator":"@cdeualmeria","twitter_site":"@cdeualmeria","twitter_misc":{"Written by":"AdminCDE","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#article","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/"},"author":{"name":"AdminCDE","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/224ef08c8bcc005f319d2713ce37ee5f"},"headline":"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing","datePublished":"2020-06-12T01:00:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/"},"wordCount":292,"commentCount":0,"publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","keywords":["Coronavirus","Salud"],"articleSection":["Diseases","Economy and Finance","EU News","Farmaceutical","Market"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/","url":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/","name":"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#primaryimage"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","datePublished":"2020-06-12T01:00:24+00:00","breadcrumb":{"@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#primaryimage","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","width":927,"height":585},{"@type":"BreadcrumbList","@id":"https:\/\/www.cde.ual.es\/en\/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cde.ual.es\/en\/"},{"@type":"ListItem","position":2,"name":"EU News","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/"},{"@type":"ListItem","position":3,"name":"Health","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/health\/"},{"@type":"ListItem","position":4,"name":"Diseases","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/health\/diseases\/"},{"@type":"ListItem","position":5,"name":"EIB to provide BioNTech with up to \u20ac100 million in debt financing for COVID-19 vaccine development and manufacturing"}]},{"@type":"WebSite","@id":"https:\/\/www.cde.ual.es\/#website","url":"https:\/\/www.cde.ual.es\/","name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","description":"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda","publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"alternateName":"CDE Almer\u00eda","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cde.ual.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cde.ual.es\/#organization","name":"Centro de Documentaci\u00f3n Europea de Almer\u00eda","url":"https:\/\/www.cde.ual.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","width":1400,"height":300,"caption":"Centro de Documentaci\u00f3n Europea de Almer\u00eda"},"image":{"@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","https:\/\/x.com\/cdeualmeria","https:\/\/www.tiktok.com\/@cdealmeria","https:\/\/www.instagram.com\/cdealmeria\/","https:\/\/www.linkedin.com\/in\/cde-almera-812b26a9\/"]},{"@type":"Person","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/224ef08c8bcc005f319d2713ce37ee5f","name":"AdminCDE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g","caption":"AdminCDE"}}]}},"_links":{"self":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/45874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/comments?post=45874"}],"version-history":[{"count":0,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/45874\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media\/16452"}],"wp:attachment":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media?parent=45874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/categories?post=45874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/tags?post=45874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}